218Ffluoro2deo
218Fluorodeoxyglucose (2-FDG) is a radioactive glucose analog used primarily in positron emission tomography (PET) scans to visualize metabolic activity in the body. It is particularly useful in oncology for detecting cancerous tumors due to their increased glucose metabolism. The compound is synthesized by replacing one of the hydroxyl groups in glucose with a fluorine atom, which makes it resistant to phosphorylation by hexokinase, an enzyme that normally metabolizes glucose. This resistance allows 2-FDG to accumulate in cells with high glucose uptake, such as cancer cells, making it visible in PET scans.
The synthesis of 2-FDG involves several steps, including the protection of the hydroxyl groups in glucose, the
In PET scans, 2-FDG is injected into the patient, and the distribution of the compound is imaged
2-FDG PET scans are non-invasive and do not require any special preparation, making them a valuable tool